Eritoran
-
Eritoran
structure -
-
CAS No:
185955-34-4
-
Formula:
C66H126N2O19P2
-
Chemical Name:
Eritoran
-
Synonyms:
α-D-Glucopyranose,3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[[(11Z)-1-oxo-11-octadecen-1-yl]amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-,1-(dihydrogen phosphate);α-D-Glucopyranose,3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[[(11Z)-1-oxo-11-octadecenyl]amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-,1-(dihydrogen phosphate);Eritoran;261504-30-7
- Categories:
-
CAS No:
Description
Eritoran is a lipid A derivative used for the treatment of severe sepsis. It is a conjugate acid of an eritoran(4-).|Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.|Eritoran is a synthetic analogue of the lipid A portion of the endotoxin lipopolysaccharide (LPS) with potential immunomodulating activity. Eritoran binds to a receptor complex composed of toll-like receptor 4 (TLR4), CD14 and MD2 (MD-2, LY96) that is present on most cells of the immune system, inhibiting the activation of the receptor complex by LPS, which may result in the inhibition of pro-inflammatory cytokine secretion and a potentially fatal systemic inflammatory response syndrome (SIRS). LPS is found in the outer membrane of Gram-negative bacteria and binds to the TLR4/CD14/MD2 receptor complex of immune cells, including macrophages, resulting in the release of pro-inflammatory cytokines.
Drug Information
Investigated for use/treatment in sepsis and septicemia.|Sepsis
Eritoran has been shown to down-regulate the intracellular generation of pro-inflammatory cytokines IL-6 and TNF-alpha in human monocytes.
50.4 to 62.7 hours
Eritoran is a toll-like receptor 4 inhibitor.
3-O-decyl-2-deoxy-6-O-(2-deoxy-3-O-(3-methoxydecyl)-6-O-methyl-2-((1-oxo-11-octadecenyl)amino)-4-O-phosphonoglucopyranosyl)-2-((1,3-dioxotetradecyl)amino)-1-(dihydroxy phosphate)glucopyranose
Eritoran Use and Manufacturing
Treatment of sepsis and other diseases due to reaction to bacterial endotoxin (endotoxin antagonist).
Human Drugs -> EU pediatric investigation plans
Computed Properties
Molecular Weight:1313.7
XLogP3:15.4
Hydrogen Bond Donor Count:7
Hydrogen Bond Acceptor Count:19
Rotatable Bond Count:59
Exact Mass:1312.84300379
Monoisotopic Mass:1312.84300379
Topological Polar Surface Area:294
Heavy Atom Count:89
Complexity:1900
Defined Atom Stereocenter Count:11
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Eritoran
-
CN
4 YRS
Business licensedTrader Supplier of Tranexamic acid,Plant extracts,nmn,Alpha Arbutin,food additives,ecdysone,Cosmetic raw materials,β-Hydroxybutyric acidInquiryUnit Price: $1314-1500 /KG FOBCAS No.: 185955-34-4Grade: Pharmaceutical Grade -
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on Eritoran
- Novopor Acquires Pressure Chemical to Scale Specialty Chemicals
- Specialty Chemicals Giant Synthomer Launches Innovation Center in Shanghai to Meet Chinese Market Needs
- Global consumption of specialty chemicals will add more than 100 billion U.S. dollars in five years
- U.S. Prince acquires specialty chemicals company Flow for US$2.1 billion
- Standard Industries acquires specialty chemicals company Grace for $7 billion
Learn More Other Chemicals
-
Cholesteryl oleyl carbonate
17110-51-9
-
2-broMo-5-iodobenzoic acid Methyl ester
717880-58-5
-
Ethyl 4-fluoro-3-nitrobenzoate
367-80-6
-
4-[2,2-dichloro-1-(4-methoxyphenyl)ethenyl]-2-methoxy-1-phenylmethoxybenzene Formula
90047-68-0
-
Dioxopromethazine hydrochloride Formula
15374-15-9
-
Phosphorodiamidic acid, tetraethyl-, 2-propenyl ester Formula
75219-49-7
-
Benzene, 4-[4'-(3-butenyl)[1,1'-bicyclohexyl]-4-yl]-1,2-difluoro-, [trans(trans)]- Structure
155266-68-5
-
1-BENZYLPIPERIDINE-4-CARBONITRILE Structure
62718-31-4
-
What is Cinchoninic acid, 6-amino-2-methyl- (6CI)
103858-07-7
-
What is 4′-Amino[1,1′-biphenyl]-4-ol
1204-79-1